Clinical trials
Completed Esophageal Squamous Cell Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 3 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 10 |
| Alliance for Clinical Trials in Oncology | 4 |
| Radiation Therapy Oncology Group | 4 |
| Roswell Park Cancer Institute | 4 |
| Novartis Pharmaceuticals | 3 |
| OHSU Knight Cancer Institute | 3 |
| BeiGene | 2 |
| Case Comprehensive Cancer Center | 2 |
| City of Hope Medical Center | 2 |
| Dana-Farber Cancer Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Squamous Cell Carcinoma | 58 |
| Esophageal Neoplasms | 39 |
| Stomach Neoplasms | 14 |
| Squamous Cell Carcinoma of Head and Neck | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Uterine Cervical Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Hepatocellular | 3 |
| Melanoma | 3 |
| Anus Neoplasms | 2 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.